Kansas City, Kan- Jon Bohnsack, a former Ironman triathlete, discovered a lump on his neck in 2022, leading to a diagnosis of pharynx squamous cell carcinoma. He opted for radiation and chemotherapy over surgery, attributing his recovery to his active lifestyle.
Jon's case was part of a clinical trial at The University of Kansas Cancer Center, which aimed to reduce radiation doses. Dr. Gregory Gan, his radiation oncologist, explained the trial's success in achieving similar cure rates with fewer side effects.
John Bohnsack, patient
- Jon, a busy father of two, is approaching three years with no evidence of disease and has changed his outlook on life.
- He shares that he noticed a lump on his throat and decided to get it checked out within a week or two.
- Jon met with a surgeon who decided against surgery due to the potential impact on his ability to speak, opting for radiation and chemotherapy instead.
Dr. Gregory Gan, Radiation Oncologist, The University of Kansas Cancer Center
- Dr. Gan explains the clinical trial John participated in, which aimed to reduce the dose of radiation while maintaining similar treatment outcomes.
- The discussion also highlighted the importance of the HPV vaccine in preventing head and neck cancers and the need for early detection and professional medical advice.
- The trial has since closed, but preliminary results show no signs of cancer, and John continues to stay active and healthy.
Tuesday, April 29th on the Morning Medical Update: Neck Cancer and Surgery A cancer journey spans from the Caribbean to Kansas City. It all started with a bump in a patient’s beard. Learn how doctors removed cancer helping a survivor avoid chemotherapy.
